TORONTO -- (MARKET WIRE) -- March 27, 2007 -- Generex Biotechnology Corporation (NASDAQ: GNBT) announced today that Dr. Eric von Hofe, Vice President and President of its Antigen Express subsidiary, is currently featured in an interview with CEOcast, Inc., where he discusses the Company’s RNAi platform. In the interview, Dr. von Hofe discusses the agreement with Beijing Daopei Hospital in Beijing, China to conduct clinical trials on a novel immunotherapeutic strategy using the Company’s proprietary methods of RNAi stimulation of the immune response against the patients’ immune cells.
